Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C L Neumann

Showing results (11-20 of 13) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 13 results.
Clinical Research in Cardiology Supplements|February 25, 2017
The German Lipoprotein Apheresis Registry (GLAR) - almost 5 years onV J J Schettler, C L Neumann, C Peter, et al.
Clinical Research in Cardiology Supplements|March 7, 2019
Lipoprotein apheresis is an optimal therapeutic option to reduce increased Lp(a) levelsV J J Schettler, C L Neumann, C Peter, et al.
Kidney & Blood Pressure Research|September 14, 2011
An erythropoietin gene polymorphism in the hypoxia-responsive element at position 3434 is possibly associated with hypertensionE G Schulz, C L Neumann, J Menne, et al.
Pageof 2

Showing results (11-20 of 13) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 13 results.
Clinical Research in Cardiology Supplements|February 25, 2017
The German Lipoprotein Apheresis Registry (GLAR) - almost 5 years onV J J Schettler, C L Neumann, C Peter, et al.
Clinical Research in Cardiology Supplements|March 7, 2019
Lipoprotein apheresis is an optimal therapeutic option to reduce increased Lp(a) levelsV J J Schettler, C L Neumann, C Peter, et al.
Kidney & Blood Pressure Research|September 14, 2011
An erythropoietin gene polymorphism in the hypoxia-responsive element at position 3434 is possibly associated with hypertensionE G Schulz, C L Neumann, J Menne, et al.
Pageof 2